- Report
- August 2025
- 393 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 384 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 384 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 476 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 386 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 386 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 489 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 361 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 265 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 474 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 281 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 294 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 364 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 377 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 290 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 464 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 140 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 476 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 207 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 380 Pages
Global
From €5208EUR$5,850USD£4,501GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more